{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:20:58Z","timestamp":1793733658298,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Res."],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>SRY-box transcription factor 4 (SOX4) is a transcription factor involved in early B cell development and has been implicated in various malignancies; however, its role in chronic lymphocytic leukemia (CLL) remains poorly understood. This study investigated the correlation between SOX4 expression and prognostic factors in CLL to determine its relevance to disease progression and clinical outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cohort of patients with CLL with a known immunoglobulin heavy chain variable region (IGHV) mutational status was analyzed for SOX4 expression using quantitative polymerase chain reaction (qPCR). Correlations between SOX4 levels and established prognostic markers including IGHV mutational status, cytogenetic abnormalities, and clinical outcomes were evaluated. Statistical analyses were performed to assess the association between SOX4 expression and patient survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Higher SOX4 expression was observed to be significantly associated with unmutated CLL (U-CLL) and adverse prognostic markers, including del(17)(p13). In contrast, lower SOX4 levels were observed in mutated CLL (M-CLL), and cytogenetic abnormalities were noted to be linked to favorable outcomes [del(13)(q21)]. Survival analysis indicated that elevated SOX4 expression was correlated with poor prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>SOX4 expression stratifies CLL subtypes and aligns with established prognostic markers. High SOX4 levels are associated with aggressive disease phenotypes, whereas low SOX4 expression is associated with better clinical outcomes. These findings indicate that SOX4 may serve as a potential biomarker for disease classification and risk stratification. Further studies are required to elucidate the biological significance of this phenomenon.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s44313-025-00086-2","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:35:45Z","timestamp":1751636145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3201-3909","authenticated-orcid":false,"given":"Ricardo","family":"Garc\u00eda-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0486-5936","authenticated-orcid":false,"given":"Jone","family":"Alberdi-Ballina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8710-7489","authenticated-orcid":false,"given":"Giovanna","family":"Farfan-Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy F.","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Larr\u00e1yoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Calasanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Mart\u00ednez-Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Panizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1660-5228","authenticated-orcid":false,"given":"Javier","family":"Larreina-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8972-7006","authenticated-orcid":false,"given":"Sof\u00eda","family":"Rinc\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5217-6319","authenticated-orcid":false,"given":"Johelys","family":"Atencio-Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Campeny-Najara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-0999","authenticated-orcid":false,"given":"Ada","family":"Esteban-Figuerola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Hernandez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-0737","authenticated-orcid":false,"given":"Puy","family":"Garrastachu-Zumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Velasco-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda Ruiz","family":"de Gaona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9630-8813","authenticated-orcid":false,"given":"Jes\u00fas","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"issue":"1","key":"86_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajh.27137","volume":"99","author":"D Ghergus","year":"2024","unstructured":"Ghergus D, Martin M, Knapp AM, et al. Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation? Am J Hematol. 2024;99(1):48\u201356. https:\/\/doi.org\/10.1002\/ajh.27137.","journal-title":"Am J Hematol"},{"issue":"4","key":"86_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/imm.12285","volume":"142","author":"R Garc\u00eda-Mu\u00f1oz","year":"2014","unstructured":"Garc\u00eda-Mu\u00f1oz R, Llorente L. Chronic lymphocytic leukaemia: Could immunological tolerance mechanisms be the origin of lymphoid neoplasms? Immunology. 2014;142(4):536\u201350. https:\/\/doi.org\/10.1111\/imm.12285.","journal-title":"Immunology"},{"key":"86_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaut.2014.10.005","volume":"56","author":"R Garc\u00eda-Mu\u00f1oz","year":"2015","unstructured":"Garc\u00eda-Mu\u00f1oz R, Feliu J, Llorente L. The top ten clues to understand the origin of chronic lymphocytic leukemia (CLL). J Autoimmun. 2015;56:81\u20136. https:\/\/doi.org\/10.1016\/j.jaut.2014.10.005.","journal-title":"J Autoimmun"},{"issue":"2","key":"86_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","volume":"20","author":"Y Kikushige","year":"2011","unstructured":"Kikushige Y, Ishikawa F, Miyamoto T, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 2011;20(2):246\u201359. https:\/\/doi.org\/10.1016\/j.ccr.2011.06.029.","journal-title":"Cancer Cell"},{"issue":"2","key":"86_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1182\/blood-2008-07-166868","volume":"113","author":"A Hadzidimitriou","year":"2009","unstructured":"Hadzidimitriou A, Darzentas N, Murray F, et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood. 2009;113(2):403\u201311. https:\/\/doi.org\/10.1182\/blood-2008-07-166868.","journal-title":"Blood"},{"issue":"10","key":"86_CR6","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","volume":"109","author":"CI Mockridge","year":"2007","unstructured":"Mockridge CI, Potter KN, Wheatley I, Neville LA, Packham G, Stevenson FK. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood. 2007;109(10):4424\u201331. https:\/\/doi.org\/10.1182\/blood-2006-11-056648.","journal-title":"Blood"},{"issue":"7","key":"86_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00277-012-1460-z","volume":"91","author":"R Garc\u00eda-Mu\u00f1oz","year":"2012","unstructured":"Garc\u00eda-Mu\u00f1oz R, Roldan Galiacho V, Llorente L. Immunological aspects in chronic lymphocytic leukemia (CLL) development. Ann Hematol. 2012;91(7):981\u201396. https:\/\/doi.org\/10.1007\/s00277-012-1460-z.","journal-title":"Ann Hematol"},{"issue":"7","key":"86_CR8","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1182\/blood.V87.7.2615.bloodjournal8772615","volume":"87","author":"F Caligaris-Cappio","year":"1996","unstructured":"Caligaris-Cappio F. B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood. 1996;87(7):2615\u201320.","journal-title":"Blood"},{"issue":"6","key":"86_CR9","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1172\/JCI24387","volume":"115","author":"M Herv\u00e9","year":"2005","unstructured":"Herv\u00e9 M, Xu K, Ng YS, et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest. 2005;115(6):1636\u201343. https:\/\/doi.org\/10.1172\/JCI24387.","journal-title":"J Clin Invest"},{"issue":"7415","key":"86_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","volume":"489","author":"M D\u00fchren-von Minden","year":"2012","unstructured":"D\u00fchren-von Minden M, \u00dcbelhart R, Schneider D, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012;489(7415):309\u201312. https:\/\/doi.org\/10.1038\/nature11309.","journal-title":"Nature"},{"issue":"6","key":"86_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ajh.21701","volume":"85","author":"U Andr\u00e9asson","year":"2010","unstructured":"Andr\u00e9asson U, Ed\u00e9n P, Peterson C, et al. Identification of uniquely expressed transcription factors in highly purified B-cell lymphoma samples. Am J Hematol. 2010;85(6):418\u201325. https:\/\/doi.org\/10.1002\/ajh.21701.","journal-title":"Am J Hematol"},{"key":"86_CR12","first-page":"215","volume-title":"Fundamental Immunology","author":"RR Hardy","year":"2013","unstructured":"Hardy RR. B-Lymphocyte development and biology. In: Paul WE, editor. Fundamental Immunology. 7th ed. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Willkins; 2013. p. 215\u201345.","edition":"7"},{"issue":"1","key":"86_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1182\/blood-2012-09-454439","volume":"121","author":"M Binder","year":"2013","unstructured":"Binder M, M\u00fcller F, Frick M, et al. CLL B-cell receptors can recognize themselves: Alternative epitopes and structural clues for autostimulatory mechanisms in CLL. Blood. 2013;121(1):239\u201341. https:\/\/doi.org\/10.1182\/blood-2012-09-454439.","journal-title":"Blood"},{"issue":"19","key":"86_CR14","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1182\/blood-2012-08-446732","volume":"121","author":"VK Nganga","year":"2013","unstructured":"Nganga VK, Palmer VL, Naushad H, et al. Accelerated progression of chronic lymphocytic leukemia in E\u03bc-TCL1 mice expressing catalytically inactive RAG1. Blood. 2013;121(19):3855-S16. https:\/\/doi.org\/10.1182\/blood-2012-08-446732.","journal-title":"Blood"},{"issue":"26","key":"86_CR15","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1182\/blood-2013-12-543801","volume":"123","author":"S Mallampati","year":"2014","unstructured":"Mallampati S, Sun B, Lu Y, et al. Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: Intricate roles for RAG1\/2 and CK1\u03b5. Blood. 2014;123(26):4064\u201376. https:\/\/doi.org\/10.1182\/blood-2013-12-543801.","journal-title":"Blood"},{"issue":"5","key":"86_CR16","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.4049\/jimmunol.1202736","volume":"190","author":"B Sun","year":"2013","unstructured":"Sun B, Mallampati S, Gong Y, Wang D, Lefebvre V, Sun X. Sox4 is required for the survival of pro-B cells. J Immunol. 2013;190(5):2080\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1202736.","journal-title":"J Immunol"},{"issue":"21","key":"86_CR17","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1182\/blood.V118.21.913.913","volume":"118","author":"B Sun","year":"2011","unstructured":"Sun B, Mallampati S, Gong Y, Wang D, Lefebvre V, Sun X. Conditional knockout of Sox4 markedly affects early B lymphopoiesis in adult mice. Blood. 2011;118(21):913. https:\/\/doi.org\/10.1182\/blood.V118.21.913.913.","journal-title":"Blood"},{"issue":"1","key":"86_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20121801","volume":"210","author":"R Hoogeboom","year":"2013","unstructured":"Hoogeboom R, van Kessel KP, Hochstenbach F, et al. A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. J Exp Med. 2013;210(1):59\u201370. https:\/\/doi.org\/10.1084\/jem.20121801.","journal-title":"J Exp Med"},{"issue":"3","key":"86_CR19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/leu.2012.238","volume":"27","author":"R Hoogeboom","year":"2013","unstructured":"Hoogeboom R, Wormhoudt TA, Schipperus MR, et al. A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient. Leukemia. 2013;27(3):738\u201340. https:\/\/doi.org\/10.1038\/leu.2012.238.","journal-title":"Leukemia"},{"issue":"3","key":"86_CR20","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","volume":"111","author":"F Murray","year":"2008","unstructured":"Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: Implications for the role of antigen selection in leukemogenesis. Blood. 2008;111(3):1524\u201333. https:\/\/doi.org\/10.1182\/blood-2007-07-099564.","journal-title":"Blood"},{"issue":"6","key":"86_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.immuni.2008.10.013","volume":"29","author":"F K\u00f6hler","year":"2008","unstructured":"K\u00f6hler F, Hug E, Eschbach C, et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity. 2008;29(6):912\u201321. https:\/\/doi.org\/10.1016\/j.immuni.2008.10.013.","journal-title":"Immunity"},{"issue":"3","key":"86_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.immuni.2007.07.018","volume":"27","author":"PF van Loo","year":"2007","unstructured":"van Loo PF, Dingjan GM, Maas A, Hendriks RW. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling. Immunity. 2007;27(3):468\u201380. https:\/\/doi.org\/10.1016\/j.immuni.2007.07.018.","journal-title":"Immunity"},{"issue":"3","key":"86_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.immuni.2007.01.012","volume":"26","author":"S Meixlsperger","year":"2007","unstructured":"Meixlsperger S, K\u00f6hler F, Wossning T, Reppel M, M\u00fcschen M, Jumaa H. Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity. 2007;26(3):323\u201333. https:\/\/doi.org\/10.1016\/j.immuni.2007.01.012.","journal-title":"Immunity"},{"issue":"26","key":"86_CR24","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910\u20136. https:\/\/doi.org\/10.1056\/NEJM200012283432602.","journal-title":"N Engl J Med"},{"issue":"1","key":"86_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.stem.2010.05.020","volume":"7","author":"D Liber","year":"2010","unstructured":"Liber D, Domaschenz R, Holmqvist PH, et al. Epigenetic priming of a pre-B cell-specific enhancer through binding of Sox2 and Foxd3 at the ESC stage. Cell Stem Cell. 2010;7(1):114\u201326. https:\/\/doi.org\/10.1016\/j.stem.2010.05.020.","journal-title":"Cell Stem Cell"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-025-00086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44313-025-00086-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-025-00086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:35:47Z","timestamp":1751636147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44313-025-00086-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1007\/s44313-025-00086-2","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}